Brain function in multiple sclerosis (MS): A 18F-DG PET study

U. Freo, F. Chierichetti, C. Carbonin, A. Cagnin, S. Cargnel, A. Carnevale, M. Dam, G. Ferlin, G. Pizzolato

Research output: Contribution to journalArticle

Abstract

Brain damage estimated by MRI partially correlates with clinical measures in MS patients. To assess wheter PET may better determine the impact of MS lesions on brain function, we evaluated 8 MS patients clinically, neuropsycologically, by MRI, and by quantitative 18F-DG. The rCMRglc values from individual MS patients were compared to a group of 7 healthy subjects (/-score analysis). In MS patients, cognitive, motor, and cerebellar impairments were paralleled, respectively, by a global rCMRglc decline or by selective decreses in basal ganglia and cerebellum. No correlation was found between the extent of white matter hyperintensities on MRI sequences and extent of metabolic abnormalities. Our data suggest that 18F-DG PET may be a good tool to quantify brain function in MS patients The correlation between metabolic and clinical characteristics may suggest the use of 18F-DG PET to assess the efficacy of experimental therapeutics.

Original languageEnglish
Pages (from-to)41
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Multiple Sclerosis
Brain
Basal Ganglia
Cerebellum
Healthy Volunteers

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Freo, U., Chierichetti, F., Carbonin, C., Cagnin, A., Cargnel, S., Carnevale, A., ... Pizzolato, G. (1997). Brain function in multiple sclerosis (MS): A 18F-DG PET study. Italian Journal of Neurological Sciences, 18(4), 41.

Brain function in multiple sclerosis (MS) : A 18F-DG PET study. / Freo, U.; Chierichetti, F.; Carbonin, C.; Cagnin, A.; Cargnel, S.; Carnevale, A.; Dam, M.; Ferlin, G.; Pizzolato, G.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 41.

Research output: Contribution to journalArticle

Freo, U, Chierichetti, F, Carbonin, C, Cagnin, A, Cargnel, S, Carnevale, A, Dam, M, Ferlin, G & Pizzolato, G 1997, 'Brain function in multiple sclerosis (MS): A 18F-DG PET study', Italian Journal of Neurological Sciences, vol. 18, no. 4, pp. 41.
Freo U, Chierichetti F, Carbonin C, Cagnin A, Cargnel S, Carnevale A et al. Brain function in multiple sclerosis (MS): A 18F-DG PET study. Italian Journal of Neurological Sciences. 1997;18(4):41.
Freo, U. ; Chierichetti, F. ; Carbonin, C. ; Cagnin, A. ; Cargnel, S. ; Carnevale, A. ; Dam, M. ; Ferlin, G. ; Pizzolato, G. / Brain function in multiple sclerosis (MS) : A 18F-DG PET study. In: Italian Journal of Neurological Sciences. 1997 ; Vol. 18, No. 4. pp. 41.
@article{76dd4bb5159640b995be55fda9168d68,
title = "Brain function in multiple sclerosis (MS): A 18F-DG PET study",
abstract = "Brain damage estimated by MRI partially correlates with clinical measures in MS patients. To assess wheter PET may better determine the impact of MS lesions on brain function, we evaluated 8 MS patients clinically, neuropsycologically, by MRI, and by quantitative 18F-DG. The rCMRglc values from individual MS patients were compared to a group of 7 healthy subjects (/-score analysis). In MS patients, cognitive, motor, and cerebellar impairments were paralleled, respectively, by a global rCMRglc decline or by selective decreses in basal ganglia and cerebellum. No correlation was found between the extent of white matter hyperintensities on MRI sequences and extent of metabolic abnormalities. Our data suggest that 18F-DG PET may be a good tool to quantify brain function in MS patients The correlation between metabolic and clinical characteristics may suggest the use of 18F-DG PET to assess the efficacy of experimental therapeutics.",
author = "U. Freo and F. Chierichetti and C. Carbonin and A. Cagnin and S. Cargnel and A. Carnevale and M. Dam and G. Ferlin and G. Pizzolato",
year = "1997",
language = "English",
volume = "18",
pages = "41",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Brain function in multiple sclerosis (MS)

T2 - A 18F-DG PET study

AU - Freo, U.

AU - Chierichetti, F.

AU - Carbonin, C.

AU - Cagnin, A.

AU - Cargnel, S.

AU - Carnevale, A.

AU - Dam, M.

AU - Ferlin, G.

AU - Pizzolato, G.

PY - 1997

Y1 - 1997

N2 - Brain damage estimated by MRI partially correlates with clinical measures in MS patients. To assess wheter PET may better determine the impact of MS lesions on brain function, we evaluated 8 MS patients clinically, neuropsycologically, by MRI, and by quantitative 18F-DG. The rCMRglc values from individual MS patients were compared to a group of 7 healthy subjects (/-score analysis). In MS patients, cognitive, motor, and cerebellar impairments were paralleled, respectively, by a global rCMRglc decline or by selective decreses in basal ganglia and cerebellum. No correlation was found between the extent of white matter hyperintensities on MRI sequences and extent of metabolic abnormalities. Our data suggest that 18F-DG PET may be a good tool to quantify brain function in MS patients The correlation between metabolic and clinical characteristics may suggest the use of 18F-DG PET to assess the efficacy of experimental therapeutics.

AB - Brain damage estimated by MRI partially correlates with clinical measures in MS patients. To assess wheter PET may better determine the impact of MS lesions on brain function, we evaluated 8 MS patients clinically, neuropsycologically, by MRI, and by quantitative 18F-DG. The rCMRglc values from individual MS patients were compared to a group of 7 healthy subjects (/-score analysis). In MS patients, cognitive, motor, and cerebellar impairments were paralleled, respectively, by a global rCMRglc decline or by selective decreses in basal ganglia and cerebellum. No correlation was found between the extent of white matter hyperintensities on MRI sequences and extent of metabolic abnormalities. Our data suggest that 18F-DG PET may be a good tool to quantify brain function in MS patients The correlation between metabolic and clinical characteristics may suggest the use of 18F-DG PET to assess the efficacy of experimental therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=33746364854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746364854&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746364854

VL - 18

SP - 41

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -